Appeal No. 2002-0869
Application No. 08/580,384
determinations which follow.
35 U.S.C. § 103
Claims 22-27 stand rejected under 35 U.S.C. § 103(a) as obvious over Galin
or Iverson in view of Bang and Esmon. Claims 28-29 stand rejected under 35 U.S.C. §
103(a) as obvious over Galin or Iverson in view of Bang and Esmon in further view of
Stocker. We vacate these rejections and remand the application to the examiner for
action consistent with the discussion herein.
Remand
Claim 22 of the present application is directed to a method of reducing intraocular
inflammation comprising the administration of a pharmacologically effective dose of
protein C to reduce said intraocular inflammation to an individual having said
inflammation. Copending application Serial No. 08/696,698 (Appeal No. 2001-1685)
included claims to related subject matter directed to a method of reducing amounts of
intraocular fibrin comprising the administration of a pharmacologically effective dose of
Protein C as to reduce the amount of intraocular fibrin in an individual having elevated
levels of intraocular fibrin. In the copending application, we reversed the rejection of the
examiner. The rejection in that case was based upon several references in common
with the rejection of the claims in the present application, particularly Iverson and Bang,
and appears to have turned on a similar issue, that of expectation of success in
3
Page: Previous 1 2 3 4 5 6 7 Next
Last modified: November 3, 2007